cloudfront

Report Detail



Pharma & HealthcareGlobal Japanese Encephalitis (JE) Vaccine Market Insights, Forecast to 2025

  • RnM2753611
  • |
  • 11 January, 2019
  • |
  • Global
  • |
  • 117 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Japanese Encephalitis (JE) Vaccine Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Japanese Encephalitis (JE) Vaccine Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Japanese Encephalitis (JE) Vaccine Market Size Growth Rate by Product
      • 1.4.2 Inactivated Vaccine
      • 1.4.3 Live Attenuated Vaccine
    • 1.5 Market by End User
      • 1.5.1 Global Japanese Encephalitis (JE) Vaccine Market Size Growth Rate by End User
      • 1.5.2 Public
      • 1.5.3 Private
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Japanese Encephalitis (JE) Vaccine Market Size
      • 2.1.1 Global Japanese Encephalitis (JE) Vaccine Revenue 2014-2025
      • 2.1.2 Global Japanese Encephalitis (JE) Vaccine Sales 2014-2025
    • 2.2 Japanese Encephalitis (JE) Vaccine Growth Rate by Regions
      • 2.2.1 Global Japanese Encephalitis (JE) Vaccine Sales by Regions
      • 2.2.2 Global Japanese Encephalitis (JE) Vaccine Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Japanese Encephalitis (JE) Vaccine Sales by Manufacturers
      • 3.1.1 Japanese Encephalitis (JE) Vaccine Sales by Manufacturers
      • 3.1.2 Japanese Encephalitis (JE) Vaccine Sales Market Share by Manufacturers
      • 3.1.3 Global Japanese Encephalitis (JE) Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Japanese Encephalitis (JE) Vaccine Revenue by Manufacturers
      • 3.2.1 Japanese Encephalitis (JE) Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Japanese Encephalitis (JE) Vaccine Revenue Share by Manufacturers (2014-2019)
    • 3.3 Japanese Encephalitis (JE) Vaccine Price by Manufacturers
    • 3.4 Japanese Encephalitis (JE) Vaccine Manufacturing Base Distribution, Product Types
      • 3.4.1 Japanese Encephalitis (JE) Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Japanese Encephalitis (JE) Vaccine Product Type
      • 3.4.3 Date of International Manufacturers Enter into Japanese Encephalitis (JE) Vaccine Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Japanese Encephalitis (JE) Vaccine Sales by Product
    • 4.2 Global Japanese Encephalitis (JE) Vaccine Revenue by Product
    • 4.3 Japanese Encephalitis (JE) Vaccine Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Japanese Encephalitis (JE) Vaccine Breakdown Data by End User

    6 North America

    • 6.1 North America Japanese Encephalitis (JE) Vaccine by Countries
      • 6.1.1 North America Japanese Encephalitis (JE) Vaccine Sales by Countries
      • 6.1.2 North America Japanese Encephalitis (JE) Vaccine Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Japanese Encephalitis (JE) Vaccine by Product
    • 6.3 North America Japanese Encephalitis (JE) Vaccine by End User

    7 Europe

    • 7.1 Europe Japanese Encephalitis (JE) Vaccine by Countries
      • 7.1.1 Europe Japanese Encephalitis (JE) Vaccine Sales by Countries
      • 7.1.2 Europe Japanese Encephalitis (JE) Vaccine Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Japanese Encephalitis (JE) Vaccine by Product
    • 7.3 Europe Japanese Encephalitis (JE) Vaccine by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Japanese Encephalitis (JE) Vaccine by Countries
      • 8.1.1 Asia Pacific Japanese Encephalitis (JE) Vaccine Sales by Countries
      • 8.1.2 Asia Pacific Japanese Encephalitis (JE) Vaccine Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Japanese Encephalitis (JE) Vaccine by Product
    • 8.3 Asia Pacific Japanese Encephalitis (JE) Vaccine by End User

    9 Central & South America

    • 9.1 Central & South America Japanese Encephalitis (JE) Vaccine by Countries
      • 9.1.1 Central & South America Japanese Encephalitis (JE) Vaccine Sales by Countries
      • 9.1.2 Central & South America Japanese Encephalitis (JE) Vaccine Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Japanese Encephalitis (JE) Vaccine by Product
    • 9.3 Central & South America Japanese Encephalitis (JE) Vaccine by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Japanese Encephalitis (JE) Vaccine by Countries
      • 10.1.1 Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales by Countries
      • 10.1.2 Middle East and Africa Japanese Encephalitis (JE) Vaccine Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Japanese Encephalitis (JE) Vaccine by Product
    • 10.3 Middle East and Africa Japanese Encephalitis (JE) Vaccine by End User

    11 Company Profiles

    • 11.1 GSK
      • 11.1.1 GSK Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GSK Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GSK Japanese Encephalitis (JE) Vaccine Products Offered
      • 11.1.5 GSK Recent Development
    • 11.2 Sanofi
      • 11.2.1 Sanofi Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi Japanese Encephalitis (JE) Vaccine Products Offered
      • 11.2.5 Sanofi Recent Development
    • 11.3 Chengdu institute of biologica
      • 11.3.1 Chengdu institute of biologica Company Details
      • 11.3.2 Company Business Overview
    • 11.3.Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Products Offered
      • 11.3.5 Chengdu institute of biologica Recent Development
    • 11.4 Wuhan Institute of Biological
      • 11.4.1 Wuhan Institute of Biological Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Products Offered
      • 11.4.5 Wuhan Institute of Biological Recent Development
    • 11.5 Lanzhou Institute of Biological
      • 11.5.1 Lanzhou Institute of Biological Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Products Offered
      • 11.5.5 Lanzhou Institute of Biological Recent Development
    • 11.6 Beijing Taitan
      • 11.6.1 Beijing Taitan Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Beijing Taitan Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Beijing Taitan Japanese Encephalitis (JE) Vaccine Products Offered
      • 11.6.5 Beijing Taitan Recent Development
    • 11.7 Valneva
      • 11.7.1 Valneva Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Valneva Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Valneva Japanese Encephalitis (JE) Vaccine Products Offered
      • 11.7.5 Valneva Recent Development
    • 11.8 Bharat Biotech
      • 11.8.1 Bharat Biotech Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Bharat Biotech Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Bharat Biotech Japanese Encephalitis (JE) Vaccine Products Offered
      • 11.8.5 Bharat Biotech Recent Development
    • 11.9 Biological E. Limited
      • 11.9.1 Biological E. Limited Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Biological E. Limited Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Biological E. Limited Japanese Encephalitis (JE) Vaccine Products Offered
      • 11.9.5 Biological E. Limited Recent Development
    • 11.10 Liaoning Chengda
      • 11.10.1 Liaoning Chengda Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Products Offered
      • 11.10.5 Liaoning Chengda Recent Development

    12 Future Forecast

    • 12.1 Japanese Encephalitis (JE) Vaccine Market Forecast by Regions
      • 12.1.1 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Japanese Encephalitis (JE) Vaccine Revenue Forecast by Regions 2019-2025
    • 12.2 Japanese Encephalitis (JE) Vaccine Market Forecast by Product
      • 12.2.1 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Product 2019-2025
      • 12.2.2 Global Japanese Encephalitis (JE) Vaccine Revenue Forecast by Product 2019-2025
    • 12.3 Japanese Encephalitis (JE) Vaccine Market Forecast by End User
    • 12.4 North America Japanese Encephalitis (JE) Vaccine Forecast
    • 12.5 Europe Japanese Encephalitis (JE) Vaccine Forecast
    • 12.6 Asia Pacific Japanese Encephalitis (JE) Vaccine Forecast
    • 12.7 Central & South America Japanese Encephalitis (JE) Vaccine Forecast
    • 12.8 Middle East and Africa Japanese Encephalitis (JE) Vaccine Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Japanese Encephalitis (JE) Vaccine Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. How long this protection lasts is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin.
      It is recommended as part of routine immunizations in countries where the disease is a problem. One or two doses are given depending on the version of the vaccine. Extra doses are not typically needed in areas where the disease is common. In those with HIV/AIDS or those who are pregnant an inactivated vaccine should be used. Immunization of travellers who plan to spend time outdoors in areas where the disease is common is recommended.
      The global Japanese Encephalitis (JE) Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Japanese Encephalitis (JE) Vaccine market based on company, product type, end user and key regions.

      This report studies the global market size of Japanese Encephalitis (JE) Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Japanese Encephalitis (JE) Vaccine in these regions.
      This research report categorizes the global Japanese Encephalitis (JE) Vaccine market by top players/brands, region, type and end user. This report also studies the global Japanese Encephalitis (JE) Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GSK
      Sanofi
      Chengdu institute of biologica
      Wuhan Institute of Biological
      Lanzhou Institute of Biological
      Beijing Taitan
      Valneva
      Bharat Biotech
      Biological E. Limited
      Liaoning Chengda

      Market size by Product
      Inactivated Vaccine
      Live Attenuated Vaccine
      Market size by End User
      Public
      Private

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Japanese Encephalitis (JE) Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Japanese Encephalitis (JE) Vaccine market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Japanese Encephalitis (JE) Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Japanese Encephalitis (JE) Vaccine submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Japanese Encephalitis (JE) Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Japanese Encephalitis (JE) Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.




      Summary:
      Get latest Market Research Reports on Japanese Encephalitis (JE) Vaccine . Industry analysis & Market Report on Japanese Encephalitis (JE) Vaccine is a syndicated market report, published as Global Japanese Encephalitis (JE) Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Japanese Encephalitis (JE) Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,618.85
      3,928.28
      5,237.70
      3,588.78
      5,383.17
      7,177.56
      472,446.00
      708,669.00
      944,892.00
      258,622.26
      387,933.39
      517,244.52
      Add To Cart Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report